TY - JOUR
T1 - Pathological variants in genes associated with disorders of sex development and central causes of hypogonadism in a whole-genome reference panel of 8380 Japanese individuals
AU - Shiga, Naomi
AU - Yamaguchi-Kabata, Yumi
AU - Igeta, Saori
AU - Yasuda, Jun
AU - Tadaka, Shu
AU - Minato, Takamichi
AU - Watanabe, Zen
AU - Kanno, Junko
AU - Tamiya, Gen
AU - Fuse, Nobuo
AU - Kinoshita, Kengo
AU - Kure, Shigeo
AU - Kondo, Akiko
AU - Tachibana, Masahito
AU - Yamamoto, Masayuki
AU - Yaegashi, Nobuo
AU - Sugawara, Junichi
N1 - Funding Information:
This work was supported in part by the Tohoku Medical Megabank Project through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; by the Reconstruction Agency, MEXT, Japan; by Japan Agency for Medical Research and Development (AMED) grants JP20 km0105001 and JP20 km0105002); AMED GRIFIN project grants JP16 km0405203 and JP17 km0405203; by the Center of Innovation Program from the Japan Science and Technology Agency (JST); by JSPS KAKENHI grants JP17K07193 (to J.Y.) and JP19H03795 (to N.Y.); and by JSFP KAKENHI Grant-in-Aid for Young Scientists B grant JP19K18626. This work was also supported by National Cancer Center Research and Development Fund grant 29-A-3 to N.Y. All computational resources were provided by the ToMMo supercomputer system ( http://sc.megabank.tohoku.ac.jp/en ), which is supported by the Facilitation of R&D Platform for AMED Genome Medicine Support conducted by AMED grant JP17km0405001. We thank all the participants of the TMM CommCohort Study and the TMM BirThree Cohort Study, as well as the staff of the Tohoku Medical Megabank Organization, Tohoku University, for their assistance. The full list of members of the Tohoku Medical Megabank Organization, Tohoku University, is available at https://www.megabank.tohoku.ac.jp/english/a201201/ . The authors would like to express their gratitude to all staff at obstetric clinics and hospitals for their kind cooperation. We would like to thank Editage ( www.editage.com ) for English language editing.
Funding Information:
This work was supported in part by the Tohoku Medical Megabank Project through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; by the Reconstruction Agency, MEXT, Japan; by Japan Agency for Medical Research and Development (AMED) grants JP20 km0105001 and JP20 km0105002); AMED GRIFIN project grants JP16 km0405203 and JP17 km0405203; by the Center of Innovation Program from the Japan Science and Technology Agency (JST); by JSPS KAKENHI grants JP17K07193 (to J.Y.) and JP19H03795 (to N.Y.); and by JSFP KAKENHI Grant-in-Aid for Young Scientists B grant JP19K18626. This work was also supported by National Cancer Center Research and Development Fund grant 29-A-3 to N.Y. All computational resources were provided by the ToMMo supercomputer system (http://sc.megabank.tohoku.ac.jp/en), which is supported by the Facilitation of R&D Platform for AMED Genome Medicine Support conducted by AMED grant JP17km0405001. We thank all the participants of the TMM CommCohort Study and the TMM BirThree Cohort Study, as well as the staff of the Tohoku Medical Megabank Organization, Tohoku University, for their assistance. The full list of members of the Tohoku Medical Megabank Organization, Tohoku University, is available at https://www.megabank.tohoku.ac.jp/english/a201201/. The authors would like to express their gratitude to all staff at obstetric clinics and hospitals for their kind cooperation. We would like to thank Editage (www.editage.com) for English language editing.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Disorders of sex development (DSD) comprises a congenital condition in which chromosomal, gonadal, or anatomical sex development is atypical. In this study, we screened for pathogenic variants in 32 genes associated with DSDs and central causes of hypogonadism (CHG) in a whole-genome reference panel including 8380 Japanese individuals constructed by Tohoku Medical Megabank Organization. Candidate pathogenic (P) or likely pathogenic (LP) variants were extracted from the ClinVar, InterVar, and Human Gene Mutation databases. Ninety-one candidate pathological variants were found in 25 genes; 28 novel candidate variants were identified. Nearly 1 in 40 (either ClinVar or InterVar P or LP) to 157 (both ClinVar and InterVar P or LP) individuals were found to be carriers of recessive DSD and CHG alleles. In these data, genes implicated in gonadal dysfunction did not show loss-of-function variants, with a relatively high tendency of intolerance for haploinsufficiency based on pLI and Episcore, both of which can be used for estimating haploinsufficiency. We report the types and frequencies of causative variants for DSD and CHG in the general Japanese population. This study furthers our understanding of the genetic causes and helps to refine genetic counseling of DSD and CHG.
AB - Disorders of sex development (DSD) comprises a congenital condition in which chromosomal, gonadal, or anatomical sex development is atypical. In this study, we screened for pathogenic variants in 32 genes associated with DSDs and central causes of hypogonadism (CHG) in a whole-genome reference panel including 8380 Japanese individuals constructed by Tohoku Medical Megabank Organization. Candidate pathogenic (P) or likely pathogenic (LP) variants were extracted from the ClinVar, InterVar, and Human Gene Mutation databases. Ninety-one candidate pathological variants were found in 25 genes; 28 novel candidate variants were identified. Nearly 1 in 40 (either ClinVar or InterVar P or LP) to 157 (both ClinVar and InterVar P or LP) individuals were found to be carriers of recessive DSD and CHG alleles. In these data, genes implicated in gonadal dysfunction did not show loss-of-function variants, with a relatively high tendency of intolerance for haploinsufficiency based on pLI and Episcore, both of which can be used for estimating haploinsufficiency. We report the types and frequencies of causative variants for DSD and CHG in the general Japanese population. This study furthers our understanding of the genetic causes and helps to refine genetic counseling of DSD and CHG.
UR - http://www.scopus.com/inward/record.url?scp=85139246161&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139246161&partnerID=8YFLogxK
U2 - 10.1038/s41439-022-00213-w
DO - 10.1038/s41439-022-00213-w
M3 - Article
AN - SCOPUS:85139246161
SN - 2054-345X
VL - 9
JO - Human Genome Variation
JF - Human Genome Variation
IS - 1
M1 - 34
ER -